Business / Finance

RSS
Trovagene reports net loss of $1 million for fourth quarter 2013

Trovagene reports net loss of $1 million for fourth quarter 2013

Sensient Technologies files definitive proxy materials with SEC, sends letter to shareholders

Sensient Technologies files definitive proxy materials with SEC, sends letter to shareholders

AMN Healthcare makes strategic investment in PipelineRx

AMN Healthcare makes strategic investment in PipelineRx

Yongye’s revenue increases 49.4% to $661.9M in fourth quarter 2013

Yongye’s revenue increases 49.4% to $661.9M in fourth quarter 2013

Chindex revenue increases 12% to $48.8M in fourth quarter 2013

Chindex revenue increases 12% to $48.8M in fourth quarter 2013

TVM Capital Healthcare Partners signs affiliation with Joslin Diabetes Center

TVM Capital Healthcare Partners signs affiliation with Joslin Diabetes Center

Almost Family agrees to acquire Caldwell Medical Center's Medicare-certified home health agency

Almost Family agrees to acquire Caldwell Medical Center's Medicare-certified home health agency

Derma Sciences' net sales increase 3% to $20.7 million in fourth quarter 2013

Derma Sciences' net sales increase 3% to $20.7 million in fourth quarter 2013

Bruker releases application note for detection of pharmaceutical and personal care products in water using EVOQ LC-MS/MS

Bruker releases application note for detection of pharmaceutical and personal care products in water using EVOQ LC-MS/MS

PhotoMedex Q4 2013 revenues up 16% to $63.5 million

PhotoMedex Q4 2013 revenues up 16% to $63.5 million

Antares Pharma reports total revenue of $4.7 million for fourth quarter 2013

Antares Pharma reports total revenue of $4.7 million for fourth quarter 2013

AnaptysBio announces strategic immuno-oncology collaboration with TESARO

AnaptysBio announces strategic immuno-oncology collaboration with TESARO

SAGE Therapeutics announces completion of $38 million Series C financing

SAGE Therapeutics announces completion of $38 million Series C financing

Discovery Laboratories reports net loss of $11.7 million for fourth quarter 2013

Discovery Laboratories reports net loss of $11.7 million for fourth quarter 2013

Aradigm reports record revenue of $4.6M in fourth quarter 2013

Aradigm reports record revenue of $4.6M in fourth quarter 2013

Knopp and NIAID collaborate to investigate eosinophil-lowering effects of dexpramipexole

Knopp and NIAID collaborate to investigate eosinophil-lowering effects of dexpramipexole

Quad-C Management makes five investments in the last 15 months

Quad-C Management makes five investments in the last 15 months

CRO services division of Galapagos to be acquired by Charles River Laboratories

CRO services division of Galapagos to be acquired by Charles River Laboratories

Galmed Pharmaceuticals prices initial public offering of 2,837,400 shares

Galmed Pharmaceuticals prices initial public offering of 2,837,400 shares

Quintiles prices secondary public offering of 15M shares of common stock

Quintiles prices secondary public offering of 15M shares of common stock

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.